Please enable JavaScript to continue using this application.

Compare $PALI vs $VNDA | Chartloom

Compare

$PALI vs $VNDA

Palisade Bio Inc · Vanda Pharmaceuticals Inc

PALI

Palisade Bio Inc

VNDA

Vanda Pharmaceuticals Inc

Compare $PALI vs $VNDA

Comparing Palisade Bio Inc and Vanda Pharmaceuticals Inc

PALIPalisade Bio Inc

VNDAVanda Pharmaceuticals Inc

PALIPalisade Bio Inc

Market cap

$267M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-38.4%

52W performance

-23.0%

FCF yield

-6.8%

VNDAVanda Pharmaceuticals Inc

Market cap

$275M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.89x

Rev growth (TTM)

6.0%

YTD performance

-44.6%

52W performance

-16.3%

FCF yield

-55.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

PALI

VNDA

Detailed metrics comparison

PALI

Palisade Bio Inc

VNDA

Vanda Pharmaceuticals Inc

Market Cap

PALI$267M

VNDA$275M

Enterprise Value

PALI$142M

VNDA$226M

Price

PALI$1.54

VNDA$4.57

P/E Ratio

PALIN/A

VNDAN/A

P/S Ratio

PALI534.63x

VNDA1.27x

EV/Sales

PALI284.28x

VNDA1.05x

EV/EBITDA

PALI0.00x

VNDA183.49x

P/B Ratio

PALI2.06x

VNDA1.29x

P/FCF Ratio

PALIN/A

VNDAN/A

EV/FCF

PALI-7.81x

VNDA-1.48x

PEG Ratio

PALIN/A

VNDAN/A

Forward P/E (NTM)

PALIN/A

VNDAN/A

Forward P/S (NTM)

PALIN/A

VNDA0.89x

Revenue (TTM)

PALI$500K

VNDA$216M

Revenue Growth (YoY)

PALIN/A

VNDA6.0%

Forward Rev Growth

PALI42864.7%

VNDA35.6%

Gross Margin (TTM)

PALI0.0%

VNDA93.7%

Operating Margin (TTM)

PALI0.0%

VNDA0.0%

EBITDA Margin (TTM)

PALI-7069.6%

VNDA-82.1%

Net Margin (TTM)

PALI-6388.2%

VNDA-127.4%

FCF Margin (TTM)

PALI-3638.0%

VNDA-70.9%

Net Income (TTM)

PALI$-32M

VNDA$-275M

FCF (TTM)

PALI$-18M

VNDA$-153M

EPS (TTM)

PALI-$0.15

VNDA-$4.56

ROE (TTM)

PALI-3347.0%

VNDA-8495.0%

ROA (TTM)

PALI-3179.0%

VNDA-5679.0%

ROIC (TTM)

PALI-3345.0%

VNDA-8320.0%

Cash

PALI$125M

VNDA$56M

Debt

PALI$0

VNDA$7M

Net Cash/Debt

PALI$125M

VNDA$49M

Current Ratio (TTM)

PALI24.26x

VNDA1.61x

Quick Ratio (TTM)

PALI23.97x

VNDA1.40x

Debt/Equity (TTM)

PALI0.00x

VNDA0.03x

Debt/Assets (TTM)

PALI0.0%

VNDA0.0%

Interest Coverage (TTM)

PALIN/A

VNDAN/A

Net Debt/EBITDA (TTM)

PALI0.00x

VNDA0.00x

Beta

PALI1.53

VNDA0.69

52W Performance

PALI-23.0%

VNDA-16.3%

YTD Performance

PALI-38.4%

VNDA-44.6%

% from 52W High

PALI-46.0%

VNDA-54.0%

% from 52W Low

PALI16.7%

VNDA7.0%

Asset Turnover (TTM)

PALI0.00x

VNDA0.45x

FCF Yield (TTM)

PALI-6.8%

VNDA-55.7%

Earnings Yield (TTM)

PALI-11.9%

VNDA-100.0%

Dividend Yield (TTM)

PALIN/A

VNDAN/A

Rule of 40

PALI-3,638.0

VNDA-64.9

EV/GP/RG

PALIN/A

VNDA0.01

Ticker research

View PALI research View VNDA research

Metric	PALI Palisade Bio Inc	VNDA Vanda Pharmaceuticals Inc
Market & Valuation
Market Cap	$267M	$275M
Enterprise Value	$142M	$226M
Price	$1.54	$4.57
P/E Ratio	N/A	N/A
P/S Ratio	534.63x	1.27x
EV/Sales	284.28x	1.05x
EV/EBITDA	0.00x	183.49x
P/B Ratio	2.06x	1.29x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.81x	-1.48x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	0.89x
Revenue & Growth
Revenue (TTM)	$500K	$216M
Revenue Growth (YoY)	N/A	6.0%
Forward Rev Growth	42864.7%	35.6%
Profitability
Gross Margin (TTM)	0.0%	93.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-7069.6%	-82.1%
Net Margin (TTM)	-6388.2%	-127.4%
FCF Margin (TTM)	-3638.0%	-70.9%
Net Income (TTM)	$-32M	$-275M
FCF (TTM)	$-18M	$-153M
EPS (TTM)	-$0.15	-$4.56
ROE (TTM)	-3347.0%	-8495.0%
ROA (TTM)	-3179.0%	-5679.0%
ROIC (TTM)	-3345.0%	-8320.0%
Financial Health
Cash	$125M	$56M
Debt	$0	$7M
Net Cash/Debt	$125M	$49M
Current Ratio (TTM)	24.26x	1.61x
Quick Ratio (TTM)	23.97x	1.40x
Debt/Equity (TTM)	0.00x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.53	0.69
52W Performance	-23.0%	-16.3%
YTD Performance	-38.4%	-44.6%
% from 52W High	-46.0%	-54.0%
% from 52W Low	16.7%	7.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.45x
FCF Yield (TTM)	-6.8%	-55.7%
Earnings Yield (TTM)	-11.9%	-100.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,638.0	-64.9
EV/GP/RG	N/A	0.01
Ticker research	View PALI research	View VNDA research

Valuation

P/S Ratio

VNDA

1.27x

PALI

534.63x

EV/FCF

PALI

-7.81x

VNDA

-1.48x

Growth & revenue

Revenue Growth TTM

VNDA

6.0%

Forward Revenue Growth

PALI

42864.7%

VNDA

35.6%

Profitability & performance

Gross Margin

VNDA

93.7%

PALI

0.0%

ROE

PALI

-3347.0%

VNDA

-8495.0%

FCF Yield %

PALI

-6.8%

VNDA

-55.7%

52-Week Performance

VNDA

-16.3%

PALI

-23.0%

Detailed metrics comparison

PALI

Palisade Bio Inc

VNDA

Vanda Pharmaceuticals Inc

Market Cap

PALI$267M

VNDA$275M

Enterprise Value

PALI$142M

VNDA$226M

Price

PALI$1.54

VNDA$4.57

P/E Ratio

PALIN/A

VNDAN/A

P/S Ratio

PALI534.63x

VNDA1.27x

EV/Sales

PALI284.28x

VNDA1.05x

EV/EBITDA

PALI0.00x

VNDA183.49x

P/B Ratio

PALI2.06x

VNDA1.29x

P/FCF Ratio

PALIN/A

VNDAN/A

EV/FCF

PALI-7.81x

VNDA-1.48x

PEG Ratio

PALIN/A

VNDAN/A

Forward P/E (NTM)

PALIN/A

VNDAN/A

Forward P/S (NTM)

PALIN/A

VNDA0.89x

Revenue (TTM)

PALI$500K

VNDA$216M

Revenue Growth (YoY)

PALIN/A

VNDA6.0%

Forward Rev Growth

PALI42864.7%

VNDA35.6%

Gross Margin (TTM)

PALI0.0%

VNDA93.7%

Operating Margin (TTM)

PALI0.0%

VNDA0.0%

EBITDA Margin (TTM)

PALI-7069.6%

VNDA-82.1%

Net Margin (TTM)

PALI-6388.2%

VNDA-127.4%

FCF Margin (TTM)

PALI-3638.0%

VNDA-70.9%

Net Income (TTM)

PALI$-32M

VNDA$-275M

FCF (TTM)

PALI$-18M

VNDA$-153M

EPS (TTM)

PALI-$0.15

VNDA-$4.56

ROE (TTM)

PALI-3347.0%

VNDA-8495.0%

ROA (TTM)

PALI-3179.0%

VNDA-5679.0%

ROIC (TTM)

PALI-3345.0%

VNDA-8320.0%

Cash

PALI$125M

VNDA$56M

Debt

PALI$0

VNDA$7M

Net Cash/Debt

PALI$125M

VNDA$49M

Current Ratio (TTM)

PALI24.26x

VNDA1.61x

Quick Ratio (TTM)

PALI23.97x

VNDA1.40x

Debt/Equity (TTM)

PALI0.00x

VNDA0.03x

Debt/Assets (TTM)

PALI0.0%

VNDA0.0%

Interest Coverage (TTM)

PALIN/A

VNDAN/A

Net Debt/EBITDA (TTM)

PALI0.00x

VNDA0.00x

Beta

PALI1.53

VNDA0.69

52W Performance

PALI-23.0%

VNDA-16.3%

YTD Performance

PALI-38.4%

VNDA-44.6%

% from 52W High

PALI-46.0%

VNDA-54.0%

% from 52W Low

PALI16.7%

VNDA7.0%

Asset Turnover (TTM)

PALI0.00x

VNDA0.45x

FCF Yield (TTM)

PALI-6.8%

VNDA-55.7%

Earnings Yield (TTM)

PALI-11.9%

VNDA-100.0%

Dividend Yield (TTM)

PALIN/A

VNDAN/A

Rule of 40

PALI-3,638.0

VNDA-64.9

EV/GP/RG

PALIN/A

VNDA0.01

Ticker research

View PALI research View VNDA research

Metric	PALI Palisade Bio Inc	VNDA Vanda Pharmaceuticals Inc
Market & Valuation
Market Cap	$267M	$275M
Enterprise Value	$142M	$226M
Price	$1.54	$4.57
P/E Ratio	N/A	N/A
P/S Ratio	534.63x	1.27x
EV/Sales	284.28x	1.05x
EV/EBITDA	0.00x	183.49x
P/B Ratio	2.06x	1.29x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.81x	-1.48x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	0.89x
Revenue & Growth
Revenue (TTM)	$500K	$216M
Revenue Growth (YoY)	N/A	6.0%
Forward Rev Growth	42864.7%	35.6%
Profitability
Gross Margin (TTM)	0.0%	93.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-7069.6%	-82.1%
Net Margin (TTM)	-6388.2%	-127.4%
FCF Margin (TTM)	-3638.0%	-70.9%
Net Income (TTM)	$-32M	$-275M
FCF (TTM)	$-18M	$-153M
EPS (TTM)	-$0.15	-$4.56
ROE (TTM)	-3347.0%	-8495.0%
ROA (TTM)	-3179.0%	-5679.0%
ROIC (TTM)	-3345.0%	-8320.0%
Financial Health
Cash	$125M	$56M
Debt	$0	$7M
Net Cash/Debt	$125M	$49M
Current Ratio (TTM)	24.26x	1.61x
Quick Ratio (TTM)	23.97x	1.40x
Debt/Equity (TTM)	0.00x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.53	0.69
52W Performance	-23.0%	-16.3%
YTD Performance	-38.4%	-44.6%
% from 52W High	-46.0%	-54.0%
% from 52W Low	16.7%	7.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.45x
FCF Yield (TTM)	-6.8%	-55.7%
Earnings Yield (TTM)	-11.9%	-100.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,638.0	-64.9
EV/GP/RG	N/A	0.01
Ticker research	View PALI research	View VNDA research